Medical Devices; Device Tracking

ICR 201105-0910-002

OMB: 0910-0442

Federal Form Document

Forms and Documents
Document
Name
Status
Supporting Statement A
2011-11-01
IC Document Collections
IC ID
Document
Title
Status
6125
Modified
ICR Details
0910-0442 201105-0910-002
Historical Active 200804-0910-007
HHS/FDA
Medical Devices; Device Tracking
Extension without change of a currently approved collection   No
Regular
Approved with change 12/12/2011
Retrieve Notice of Action (NOA) 05/10/2011
  Inventory as of this Action Requested Previously Approved
12/31/2014 36 Months From Approved 12/31/2011
17,915 0 259,177
621,279 0 3,407,184
0 0 0

Manufacturers receiving FDA orders to track a device, whose failure would likely have serious adverse health consequences, and which is implanted in humans for more than 1 year, or is life-sustaining or life-supporting and used outside a device user facility, are required to collect/maintain current tracking information about the identity and location of the device during distribution, and about the identity and location of patients receiving the device, including certain physician information. Distributors must report this data to manufacturers.

US Code: 21 USC 360(e)(2) Name of Law: null
   US Code: 21 USC 360(e)(1) Name of Law: null
  
None

Not associated with rulemaking

  75 FR 69447 11/12/2010
76 FR 26304 05/06/2011
No

1
IC Title Form No. Form Name
Medical Devices; Device Tracking

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 17,915 259,177 0 0 -241,262 0
Annual Time Burden (Hours) 621,279 3,407,184 0 0 -2,785,905 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
No
No
The burden hours and responses have been adjusted as the result of re-estimating and re-evaluating submissions and tracking data by the agency. FDA attributes the reduction to the decreased number of tracking orders issued since original estimates were provided. More specifically, while the Safe Medical Devices Act of 1990 required tracking by all manufacturers of certain devices, FDAMA (enacted in 1997) provides that devices subject to tracking would be determined at the Agency's discretion and only upon order by FDA.

$6,292
No
No
No
No
No
Uncollected
Daniel Gitteson 3017965156 daniel.gitteson@fda.hhs.gov

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
05/10/2011


© 2024 OMB.report | Privacy Policy